Eversept Partners, LP Puma Biotechnology, Inc. Transaction History
Eversept Partners, LP
- $993 Million
- Q2 2025
A detailed history of Eversept Partners, LP transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 240,688 shares of PBYI stock, worth $1.17 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
240,688
Previous 275,788
12.73%
Holding current value
$1.17 Million
Previous $816,000
1.1%
% of portfolio
0.08%
Previous 0.09%
Shares
38 transactions
Others Institutions Holding PBYI
# of Institutions
124Shares Held
33.1MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.1 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$18.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$9.78 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.13 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $222M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...